Contact
Please use this form to send email to PR contact of this press release:
Inventiva receives FDA Fast Track designation for lead asset lanifibranor in NASH
TO:
Please use this form to send email to PR contact of this press release:
Inventiva receives FDA Fast Track designation for lead asset lanifibranor in NASH
TO: